Vebreltinib for Advanced or Metastatic CCS

NCT07153887 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Clear Cell Sarcoma (CCS)

Interventions

DRUG: Vebreltinib
OTHER: Standard medical treatment

Sponsor

Second Affiliated Hospital, School of Medicine, Zhejiang University